Stocks and Investing Stocks and Investing
Tue, July 19, 2022

Pete Stravropoulos Initiated (ARCT) at Buy and Held Target at $39 on, Jul 19th, 2022


Published on 2024-10-27 22:01:53 - WOPRAI, Pete Stravropoulos
  Print publication without navigation


Pete Stravropoulos of Cantor Fitzgerald, Initiated "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy and Held Target at $39 on, Jul 19th, 2022.

Pete has made no other calls on ARCT in the last 4 months.



There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 2 agree with Pete's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $18 on, Wednesday, May 11th, 2022
  • Ed Arce of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $19 on, Tuesday, May 10th, 2022


These are the ratings of the 3 analyists that currently disagree with Pete


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $8 on, Tuesday, May 24th, 2022
  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $17 on, Tuesday, May 10th, 2022
  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $105 on, Friday, March 25th, 2022
Contributing Sources